|
| 36781985 | Apolipoprotein C3 induces inflammasome activation only in its delipidated form. | Nat Immunol | 2023 |
| 38045410 | Host-derived oxidized phospholipids initiate effector-triggered immunity fostering lethality upon microbial encounter. | | 2023 |
| 37848630 | Oxidized phospholipids in cardiovascular disease. | | 2023 |
| 37338713 | On-treatment platelet reactivity through the thromboxane A or P2Y12 platelet receptor pathways is not affected by pelacarsen. | | 2023 |
| 37211249 | High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction. | | 2023 |
| 37164837 | APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia. | | 2023 |
| 37100699 | Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial. | | 2023 |
| 35025993 | Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. | Eur Heart J | 2022 |
| 35902351 | Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. | J Clin Lipidol | 2022 |
| 35653195 | Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. | JCI insight | 2022 |
| 36008083 | Shared Mechanisms between Cardiovascular Disease and NAFLD. | Semin Liver Dis | 2022 |
| 35688187 | Development and validation of an isoform-independent monoclonal antibody-based ELISA for measurement of lipoprotein(a). | Journal of Lipid Research | 2022 |
| 35935999 | B-1b Cells Have Unique Functional Traits Compared to B-1a Cells at Homeostasis and in Aged Hyperlipidemic Mice With Atherosclerosis. | Frontiers in Immunology | 2022 |
| 36402670 | Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study. | Journal of Clinical Lipidology | 2022 |
| 35917178 | The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis. | JCI Insight | 2022 |
| 35218041 | Bioactive lipids and metabolic syndrome-a symposium report. | Annals of the New York Academy of Sciences | 2022 |
| 34696496 | Longitudinal Assessment of Lipoprotein(a) Levels in Perinatally HIV-Infected Children and Adolescents. | Viruses | 2021 |
| 33798466 | Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet Diabetes and Endocrinology,The | 2021 |
| 33636163 | Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements. | J Lipid Res | 2021 |
| 34278710 | Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice. | Aging Cell | 2021 |
| 34102100 | Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8<sup>+</sup> TÂ cells in tumors. | Immunity | 2021 |
| 33872986 | Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen. | Atherosclerosis | 2021 |
| 32990984 | A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice. | Journal of Bone and Mineral Research | 2021 |
| 34846914 | Oxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency. | Circulation | 2021 |
| 31111151 | Statin therapy increases lipoprotein(a) levels. | Eur Heart J | 2020 |
| 32029622 | An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. | Science | 2020 |
| 32362324 | Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. | Immunity | 2020 |
| 31893580 | Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. | New England Journal of Medicine | 2020 |
| 31893480 | Statins and increases in Lp(a): an inconvenient truth that needs attention. | Eur Heart J | 2020 |
| 32054669 | ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis. | Heart | 2020 |
| 32160811 | Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation. | Circ Res | 2020 |
| 32043907 | Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia. | Nucleic Acid Therapeutics | 2020 |
| 31761566 | Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. | Cell Metab | 2020 |
| 32641432 | Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a). | J Lipid Res | 2020 |
| 32635160 | CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Mice. | Antibodies | 2020 |
| 32860031 | Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. | European Heart Journal | 2020 |
| 31549940 | Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis. | Circulation Research | 2019 |
| 31777768 | Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles. | Journal of the Endocrine Society | 2019 |
| 31676683 | Erratum: A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma. | Journal of Lipid Research | 2019 |
| 31881148 | Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia. Reply. | New England Journal of Medicine | 2019 |
| 31881147 | Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia. | New England Journal of Medicine | 2019 |
| 32159096 | Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography. | CJC Open | 2019 |
| 31551368 | Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. | J Lipid Res | 2019 |
| 30553772 | CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice. | Mol Metab | 2019 |
| 30563909 | A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma. | Journal of Lipid Research | 2019 |
| 29850765 | Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids. | Cardiovasc Res | 2019 |
| 31092690 | ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance. | J Lipid Res | 2019 |
| 30968745 | Apolipoprotein Profiles in Very Preterm and Term-Born Preschool Children. | Journal of the American Heart Association | 2019 |
| 31390500 | Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome. | New England Journal of Medicine | 2019 |
| 30726759 | RNA-Targeted Therapeutics. | | 2019 |